10133-25-2

Usage

Uses

Used in Pharmaceutical Industry:
Benzo[b]thiophene-4-carbaldehyde is utilized as an intermediate in the synthesis of various pharmaceuticals. Its unique chemical structure allows it to be a key component in the development of new drugs, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, Benzo[b]thiophene-4-carbaldehyde serves as an intermediate in the production of agrochemicals. Its involvement in the synthesis of these compounds plays a crucial role in the development of effective agricultural products, such as pesticides and herbicides, to protect crops and enhance agricultural productivity.
Used in Flavor and Fragrance Industry:
Benzo[b]thiophene-4-carbaldehyde is employed as a flavor and fragrance ingredient in the production of perfumes and other scented products. Its strong odor makes it a valuable component in creating distinctive and appealing scents for various applications, including cosmetics, personal care products, and household items.
Used in Organic Compounds Synthesis:
This chemical compound is also used as an intermediate in the synthesis of other organic compounds. Its versatile structure allows it to be incorporated into a wide range of organic molecules, expanding the scope of chemical research and development in various industries.

Upstream product

• 16587-47-6 6-methylbenzo[b]thiophene 
• 14315-11-8 4-methylbenzo[b]thiophene 
• 94-36-0 dibenzoyl peroxide 
• 10134-95-9 benzothiophen-4-carboxic acid 
• 51830-54-7 benzo[b]thiophen-4-ylmethanol 
• 17347-34-1 benzo[b]thiophene-4-carbonitrile 
• 5118-13-8 4-bromobenzo[b]thiophene 

Relevant academic research and scientific papers

BCL-2 INHIBITOR

Disclosed herein is a compound of Formula (I) for inhibiting both Bcl-2 wild type and mutated Bcl-2, in particular, Bcl-2 G101V and D103Y, and a method of using the compound disclosed herein for treating dysregulated apoptotic diseases.

BENZISOXAZOLE COMPOUND

Disclosed is a compound represented by the general formula (I) or a salt thereof: wherein any one of R1, R2 and R3 represents a group represented by the formula: -(CH2)m-NR11R12 (wherein m is 1 or 2; and R11 and R12 independently represent a hydrogen atom or a C1-6 alkyl group or may, together with a nitrogen atom to which R11 and R12 are bound, form a 4- or 5-membered cyclic group); the remaining two or R1, R2 and R3 independently represent a group represented by the formula: -(O)n-R21 (wherein n is 0 or 1; and R21 represents a hydrogen atom, a C1-6 alkyl group, a C2-6 alkenyl group, a C2-6 alkynyl group, or the like); and R4 represents a C1-6 alkyl group which may have a substituent or the like.

PURINE DERIVATIVES AS KINASE INHIBITORS

The present invention provides kinase inhibitors of Formula I.

N-ALKOXYALKYL-N,N-DIALKYLAMINE DERIVATIVES OR SALTS THEREOF, AND REMEDIES FOR NERVE DEGENERATION DISEASES CONTAINING THE SAME

An N-alkoxyalkyl-N,N-dialkylamine derivative represented by the following general formula [1]: wherein the ring D represents a 5- or 6-membered heterocyclic ring or hydrocarbon ring; R3 and R4, which are the same or different, represent an unsubstituted or substituted alkyl, cycloalkyl or aralkyl group; and R1, R2, R5, R6, R7, R8, m and n are as defined in the specification, or a salt thereof has an anti-hypoxic activity, a nerve-protecting activity and a nerve regeneration promoting activity and is useful for the treatment of neurodegenerative diseases.

UROKINASE INHIBITORS

Disclosed are benzothiophene and thienothiophene derivatives useful for inhibiting urokinase activity.

5-[Substituted bicyclic aryl or heteroaryl]cyclohexane-1,3-dione herbicides

The invention concerns novel compounds of the formula I STR1 wherein: A is selected from CH and N; B is selected from oxygen, sulfur, CH2 and the group N-Z wherein Z is selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, cy